The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A00042 | Pages : 250 | Category : Life Sciences
The global custom antibody services market was valued at $0.6 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Report Code : A324397 | Pages : 233 | Category : Life Sciences
